105 filings
10-Q
2024 Q1
TRML
Tourmaline Bio Inc
Quarterly report
13 May 24
4:18pm
8-K
TRML
Tourmaline Bio Inc
13 May 24
Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
7:15am
ARS
2023 FY
TRML
Tourmaline Bio Inc
19 Apr 24
Annual report to shareholders
4:05pm
DEFA14A
TRML
Tourmaline Bio Inc
19 Apr 24
Additional proxy soliciting materials
4:04pm
DEF 14A
TRML
Tourmaline Bio Inc
Definitive proxy
19 Apr 24
4:02pm
S-8
f4a77x91004etn brr55
19 Mar 24
Registration of securities for employees
5:10pm
8-K
g23wlxq2
19 Mar 24
Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:09am
8-K
fhd9jn 5o4rb1r
26 Jan 24
Other Events
4:12pm
424B5
7ko4qq 5v82k
26 Jan 24
Prospectus supplement for primary offering
4:08pm
424B5
vk3h39o
24 Jan 24
Prospectus supplement for primary offering
9:20pm
8-K
ewiecixn5i 01
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
vx0w8uc fnwqhiaovz
8 Jan 24
Regulation FD Disclosure
9:19am
8-K
mwzf217ar9od
14 Dec 23
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board
8:27am
8-K
ppjpo2s0jld exs8l
30 Nov 23
Departure of Directors or Certain Officers
8:25am
8-K
vjn8o
14 Nov 23
Index to Unaudited Condensed Financial Statements
5:15pm
8-K
etvok8
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
S-8
l7s8fkply4vurk sop
20 Oct 23
Registration of securities for employees
9:23pm
8-K
tj6lyy26oio0w
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm